Pnc Financial Services Group, Inc. Longeveron Inc. Transaction History

Pnc Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.25 - $2.51 $3,500 - $7,027	2,800 Added 1647.06%	2,970 $4,000
Q3 2023 Nov 13, 2023	SELL	$2.15 - $3.59 $107 - $179	-50 Reduced 22.73%	170 $0
Q4 2021 Feb 11, 2022	SELL	$2.92 - $42.3 $20 - $296	-7 Reduced 3.08%	220 $2,000
Q3 2021 Nov 05, 2021	BUY	$3.4 - $8.3 $771 - $1,884	227 New	227 $0

1.18K

Ticker LGVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,925,940
Market Cap $12.2M
Description
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult ...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.